Measuring remaining liver function after surgery
Part of Digestive system clinical trials.
This study checks how accurately a special scan (GSA) measures how well the remaining part of your liver works after surgery for liver, bile duct, or gallbladder disease. It aims to improve how doctors predict recovery and plan care after the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had or will have surgery for a liver, bile duct, or gallbladder condition.
- You have not lost more than 10% of your body weight in the 6 months before surgery.
- You do not have cancer that has spread to other parts of your body (distant metastases).
- Your heart, lungs, and kidneys are functioning reasonably well.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people do after surgery for liver, bile duct, or pancreas cancer, using a body composition test (the “inBody” test). It may help doctors understand which body changes after surgery are linked to better or worse recovery.
This study tests a special scan to predict complications before liver tumor treatment. It aims to help doctors plan safer surgery or ablation by checking how well your liver will handle the treatment.
This trial studies how well the liver works after stereotactic body radiation therapy (SBRT) for cancer that spread to the liver. If you had this specific type of radiation in three large doses, you may help researchers learn more about liver recovery.
This study tests a new way to measure how well your liver grows back and heals after part of it is removed. The goal is to predict and prevent complications after surgery.
This study tests a new imaging method that uses a special substance to find liver cancer cells. It may help doctors see if the cancer has come back after treatment, which could guide next steps.
This study looks at whether special scans can help doctors better predict how aggressive a person's liver cancer (hepatocellular carcinoma) will be, especially right after surgery. If you are planning to have surgery to remove the tumor as your first treatment, this trial might be a good fit.
Hear when a new Both Benign and Malignant Liver Mass trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.